BRAINLIFE.ORG




Neuro-Oncology Reviews




Volume 26 Number 6
31 March 2024




Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 6, 31 March








Hashemi M, Mousavian Roshanzamir S, Orouei S, Daneii P, Raesi R, Zokaee H, Bikarannejad P, Salmani K, Khorrami R, Deldar Abad Paskeh M, Salimimoghadam S, Rashidi M, Hushmandi K, Taheriazam A, Entezari M.
Shedding light on function of long non-coding RNAs (lncRNAs) in glioblastoma.
Noncoding RNA Res. 2024 Feb 6;9(2):508-522. doi: 10.1016/j.ncrna.2024.02.002. PMID: 38511060. Review. ˍ




Rodriguez B, Rivera D, Zhang JY, Brown C, Young T, Williams T, Huq S, Mattioli M, Bouras A, Hadjpanayis CG.
Magnetic Hyperthermia Therapy for High-Grade Glioma: A State-of-the-Art Review.
Pharmaceuticals (Basel). 2024 Feb 26;17(3):300. doi: 10.3390/ph17030300. PMID: 38543086. Review. ˍ




Azzarelli R, Gauthier LR, Pineda JR, Marques-Torrejon MA.
Editorial: Tumor accommodation: the importance of the niche in neurological tumors.
Front Oncol. 2024 Mar 5;14:1383594. doi: 10.3389/fonc.2024.1383594. PMID: 38505590. Editorial. ˍ




*Marino N, Bedeschi M, Vaccari ME, Cambiaghi M, Tesei A.
Glitches in the brain: the dangerous relationship between radiotherapy and brain fog.
Front Cell Neurosci. 2024 Mar 7;18:1328361. doi: 10.3389/fncel.2024.1328361. PMID: 38515789. Review. ˍ




Zhai W, Yu Q, Wu H.
The efficacy and safety of novel antiepileptic drugs in treatment of epilepsy of patients with brain tumors.
Front Neurol. 2024 Mar 7;15:1344775. doi: 10.3389/fneur.2024.1344775. PMID: 38523608. Review. ˍ




Fernando D, Ahmed AU, Williams BRG.
Therapeutically targeting the unique disease landscape of pediatric high-grade gliomas.
Front Oncol. 2024 Mar 8;14:1347694. doi: 10.3389/fonc.2024.1347694. PMID: 38525424. Review. ˍ




*Tripathy DK, Panda LP, Biswal S, Barhwal K.
Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches.
Front Pharmacol. 2024 Mar 8;15:1355242. doi: 10.3389/fphar.2024.1355242. PMID: 38523646. Review. ˍ




Mazarakis NK, Robinson SD, Sinha P, Koutsarnakis C, Komaitis S, Stranjalis G, Short SC, Chumas P, Giamas G.
Management of glioblastoma in elderly patients: A review of the literature.
Clin Transl Radiat Oncol. 2024 Mar 10;46:100761. doi: 10.1016/j.ctro.2024.100761. PMID: 38500668. Review. ˍ




Gupta T, Chatterjee A.
Existing and Evolving Landscape of Medulloblastoma: Towards Optimization and Personalization.
Diagnostics (Basel). 2024 Mar 12;14(6):598. doi: 10.3390/diagnostics14060598. PMID: 38535019. Editorial. ˍ




*Karve AS, Desai JM, Gadgil SN, Dave N, Wise-Draper TM, Gudelsky GA, Phoenix TN, DasGupta B, Yogendran L, Sengupta S, Plas DR, Desai PB.
A Review of Approaches to Potentiate the Activity of Temozolomide against Glioblastoma to Overcome Resistance.
Int J Mol Sci. 2024 Mar 12;25(6):3217. doi: 10.3390/ijms25063217. PMID: 38542190. Review. ˍ




d'Amati A, Bargiacchi L, Rossi S, Carai A, Bertero L, Barresi V, Errico ME, Buccoliero AM, Asioli S, Marucci G, Del Baldo G, Mastronuzzi A, Miele E, D'Antonio F, Gessi M, Antonelli M, Gianno F.
Pediatric CNS tumors and 2021 WHO classification: what do oncologists need from pathologists?
Front Mol Neurosci. 2024 Mar 13;17:1268038. doi: 10.3389/fnmol.2024.1268038. PMID: 38544524. Review. ˍ




Evans A, Prather KY, Battiste J, Fung KM, Dunn IF, Graffeo CS.
Genetically Distinct Oligosarcoma Arising from Oligodendroglioma: Systematic Review & Illustrative Case Example.
World Neurosurg. 2024 Mar 13:S1878-8750(24)00403-0. doi: 10.1016/j.wneu.2024.03.028. PMID: 38490447. Case report; Review˰ ˍ




Lim SH, Yee GT, Khang D.
Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier.
Int J Nanomedicine. 2024 Mar 13;19:2529-2552. doi: 10.2147/IJN.S450853. PMID: 38505170. Review. ˍ




Onciul R, Brehar FM, Toader C, Covache-Busuioc RA, Glavan LA, Bratu BG, Costin HP, Dumitrascu DI, Serban M, Ciurea AV.
Deciphering Glioblastoma: Fundamental and Novel Insights into the Biology and Therapeutic Strategies of Gliomas.
Curr Issues Mol Biol. 2024 Mar 13;46(3):2402-2443. doi: 10.3390/cimb46030153. PMID: 38534769. Review. ˍ




Palavani LB, Ferreira MY, Borges PGLB, Bandeira L, da Silva Semione G, Almeida MV, Verly G, Polverini AD, Andreão FF, Camerotte R, Ferreira C, Paiva W, Bertani R, Boockvar J.
Ultrasound-Guided Resection of High-Grade Gliomas: A Single-Arm Meta-Analysis.
World Neurosurg. 2024 Mar 13:S1878-8750(24)00418-2. doi: 10.1016/j.wneu.2024.03.033. PMID: 38490442. Meta-analysis˰ ˍ




*Sung SY, Song JH, Kim BH, Kwak YK, Kim KS, Yoo GS, Byun HK, Kim YJ, Kim YS.
Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 1. Brain and head and neck.
Radiat Oncol J. 2024 Mar 14;42(1):17-31. doi: 10.3857/roj.2023.00899. PMID: 38549381. Guidelines. ˍ




Timmermann B, Alapetite C, Dieckmann K, Kortmann RD, Lassen-Ramshad Y, Maduro JH, Ramos Albiac M, Ricardi U, Weber DC.
ESTRO-SIOPE guideline: Clinical management of radiotherapy in atypical teratoid/rhabdoid tumors (AT/Rts).
Radiother Oncol. 2024 Mar 14:110227. doi: 10.1016/j.radonc.2024.110227. PMID: 38492671. Guidelines. ˍ




Al-Lami BS, Al-Lami BS, Al-Lami YS.
PET/CT in comparison with PET/MRI as an imaging modality in the management of Gliomas-A systematic review and meta analysis.
J Med Imaging Radiat Sci. 2024 Mar 15:S1939-8654(24)00021-3. doi: 10.1016/j.jmir.2024.02.008. PMID: 38490940. Review; Meta-analysis˰ ˍ








Brunasso L, Avallone C, Florena AM, Grasso G.
Infratentorial Relapsing Neuroglial Tumors in Adults: Management and Unsolved Issues-A Systematic Review.
Brain Sci. 2024 Mar 18;14(3):286. doi: 10.3390/brainsci14030286. PMID: 38539674. Review. ˍ




Mulhem A.
Primary glioblastoma multiform (GBM) of the optic nerve and chiasma: A case report and systematic review of the literature.
Clin Case Rep. 2024 Mar 20;12(3):e8636. doi: 10.1002/ccr3.8636. PMID: 38515994. Case report; Review. ˍ




Aghajani M, Jalilzadeh N, Aghebati-Maleki A, Yari A, Tabnak P, Mardi A, Saeedi H, Aghebati-Maleki L, Baradaran B.
Current approaches in glioblastoma multiforme immunotherapy.
Clin Transl Oncol. 2024 Mar 21. doi: 10.1007/s12094-024-03395-7. PMID: 38512448. Review˰ ˍ




Begley SL, McBriar JD, Pelcher I, Schulder M.
Intraoperative MRI: A Review of Applications Across Neurosurgical Specialties.
Neurosurgery. 2024 Mar 26. doi: 10.1227/neu.0000000000002933. PMID: 38530004. Review˰ ˍ




*Watanabe S, Nonaka T, Maeda M, Yamada M, Sugii N, Hashimoto K, Takano S, Koyanagi T, Arakawa Y, Ishikawa E.
Recent Status of Phase I Clinical Trials for Brain Tumors: A Regulatory Science Study of Exploratory Efficacy Endpoints.
Ther Innov Regul Sci. 2024 Mar 26. doi: 10.1007/s43441-024-00644-3. PMID: 38530629. Review; Meta-analysis. ˍ




Nabavizadeh A, Galldiks N, Veronesi M, Lohmann P, McConathy JE, Johnson DR, Aboian MS, Barajas RF Jr, Ivanidze J.
Introducing the American Society of Neuroradiology PET-Guided Diagnosis and Management in Neuro-Oncology Study Group.
AJNR Am J Neuroradiol. 2024 Mar 28. doi: 10.3174/ajnr.A8243. PMID: 38548306. Editorial˰ ˍ




Valerius AR, Webb LM, Sener U.
Novel Clinical Trials and Approaches in the Management of Glioblastoma.
Curr Oncol Rep. 2024 Mar 28. doi: 10.1007/s11912-024-01519-4. PMID: 38546941. Review˰ ˍ




*Khalighi S, Reddy K, Midya A, Pandav KB, Madabhushi A, Abedalthagafi M.
Artificial intelligence in neuro-oncology: advances and challenges in brain tumor diagnosis, prognosis, and precision treatment.
NPJ Precis Oncol. 2024 Mar 29;8(1):80. doi: 10.1038/s41698-024-00575-0. PMID: 38553633. Review. ˍ




Menegaz de Almeida A, Viana P, Marinheiro G, Hoffmann Relvas J, Lopes L, Lima Guilherme G, Zanette Giusti JA, Oliveira P, Azevedo Silva Kaiser Cabral MA, Carvalho Santos R, Medani K.
Hypertonic Saline Solution Versus Mannitol for Brain Relaxation During Craniotomies: A Systematic Review and Updated Meta-Analysis.
Neurosurgery. 2024 Mar 29. doi: 10.1227/neu.0000000000002929. PMID: 38551382. Review; Meta-Analysis˰ ˍ